BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32048533)

  • 21. Re: Craniocaudal Retroperitoneal Node Length as a Risk Factor for Relapse from Clinical Stage I Testicular Germ Cell Tumor.
    Richie JP
    J Urol; 2015 Dec; 194(6):1633. PubMed ID: 26582668
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of magnetic resonance imaging and computed tomography in the treatment evaluation of retroperitoneal lymph-node metastases of non-seminomatous testicular tumors.
    Hogeboom WR; Hoekstra HJ; Mooyaart EL; Sleijfer DT; Freling NJ; Willemse PH; Schraffordt Koops H
    Eur J Radiol; 1991; 13(1):31-6. PubMed ID: 1716204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of retroperitoneal lymph node metastases in patients with non-seminomatous testicular cancer in clinical stage I.
    Fosså SD; Ous S; Stenwig AE; Lien HH; Aass N; Kaalhus O
    Eur Urol; 1990; 17(2):107-12. PubMed ID: 2155789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive models for lymph node metastases in patients with testicular germ cell tumors.
    Mao Y; Hedgire S; Prapruttam D; Harisinghani M
    Abdom Imaging; 2015 Oct; 40(8):3196-205. PubMed ID: 26288987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shape of retroperitoneal lymph nodes at computed tomography does not correlate to metastatic disease in early stage non-seminomatous testicular tumors.
    Lien HH; Lindsköld L; Stenwig AE; Ous S; Fosså SD
    Acta Radiol; 1987; 28(3):271-3. PubMed ID: 2820452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reduced retroperitoneal lymphadenectomy for clinical stage I non seminomatous germ cell testicular cancer].
    Valdevenito Sepúlveda JP; Merhe Nieva E; Valdevenito Sepúlveda R; Cuevas Toro M; Gómez Gallo A; Bermúdez Luna H; Contreras Meléndez L; Gallegos Méndez I; Gallardo Escobar J; Palma Ceppi C
    Arch Esp Urol; 2007 Apr; 60(3):245-54. PubMed ID: 17601299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Retroperitoneal recurrence of non-seminomatous testicular tumors: computerized tomography findings before retroperitoneal lymph node excision].
    Hosten N; Stroszczynski C; Rick O; Lemke M; Felix R
    Rofo; 1999 Jan; 170(1):61-5. PubMed ID: 10071646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center.
    Nicolai N; Tarabelloni N; Gasperoni F; Catanzaro M; Stagni S; Torelli T; Tesone A; Bettin L; Necchi A; Giannatempo P; Raggi D; Colecchia M; Piva L; Salvioni R; Paganoni AM; Pizzocaro G; Biasoni D
    J Urol; 2018 Mar; 199(3):741-747. PubMed ID: 28964782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer.
    Drieskens O; Stroobants S; Gysen M; Vandenbosch G; Mortelmans L; Vergote I
    Gynecol Obstet Invest; 2003; 55(3):130-4. PubMed ID: 12865590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of multislice computed tomography and magnetic resonance imaging in the diagnosis of retroperitoneal spread of testicular cancer: a literature review.
    Hansen J; Jurik AG
    Acta Radiol; 2009 Nov; 50(9):1064-70. PubMed ID: 19863418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases.
    Stecco A; Buemi F; Cassarà A; Matheoud R; Sacchetti GM; Arnulfo A; Brambilla M; Carriero A
    Radiol Med; 2016 Jul; 121(7):537-45. PubMed ID: 27033474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphography in retroperitoneal metastases in non-seminoma testicular tumor patients with a normal CT scan.
    Lien HH; Fosså SD; Ous S; Stenwig AE
    Acta Radiol Diagn (Stockh); 1983; 24(4):319-22. PubMed ID: 6637571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound and ultrasound guided biopsy, CT and lymphography in the diagnosis of retroperitoneal metastases in testicular cancer.
    Damgaard-Pedersen K; von der Maase H
    Scand J Urol Nephrol Suppl; 1991; 137():139-44. PubMed ID: 1947835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic accuracy of lymphangiography in the demonstration of histologically verified retroperitoneal lymph node metastases of testicular tumours.
    Hegedüs M; Farkas L; Székely J; Török A; Frang D
    Int Urol Nephrol; 1985; 17(3):245-54. PubMed ID: 3910605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retroperitoneal anomalies in men with testicular germ cell tumours.
    Holt PJ; Adshead JM; Filiadis I; Christmas TJ
    BJU Int; 2007 Feb; 99(2):344-6. PubMed ID: 17026596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of computed tomographic examination of the pelvis in the management of testicular germ cell tumours.
    White PM; Howard GC; Best JJ; Wright AR
    Clin Radiol; 1997 Feb; 52(2):124-9. PubMed ID: 9043046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The assesment of significance of the retroperitoneal lymph node dissection in proximity of metastatic tumor with main vessels in patients with germ cell testicular tumors].
    Tereshin OS; Zotov SP; Vazhenin AV; Mamonova AO
    Vestn Khir Im I I Grek; 2013; 172(1):94-8. PubMed ID: 23808237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?--Results of a study in 50 patients.
    Cremerius U; Wildberger JE; Borchers H; Zimny M; Jakse G; Günther RW; Buell U
    Urology; 1999 Nov; 54(5):900-4. PubMed ID: 10565755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.